Although several studies suggest that RKIP can potentially serve as a diagnostic biomarker, RKIP levels might be considered independently of other major clinical markers, such as tumor differentiation grade, size, and estrogen receptor status [186]. This evidence concerns the gene PEBP1 and neoplasm.